RxSight Q2 2026 Earnings: Alcon Revenue Offsets a 19% Product Sales DeclineTradingKey·Aug 5 at 04:38 PMRXST+0.16%ALC+0.10%
RxSight Q2 FY26 net loss widens 2.6% to $12.1 million; revenue rises 0.3% to $33.7 millionPUBT·Aug 5 at 04:24 PMRXST+0.16%ALC+0.10%
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules | RXST Stock NewsStockTitan·Jul 26 at 07:00 AMRXST+0.16%
AST SpaceMobile EVP and Chief of Staff Christopher E. Turco files initial beneficial ownership statementPUBT·Jul 24 at 07:30 AMASTS-9.18%ASTX-17.96%
Aziz Mottiwala named President and CEO as Ron Kurtz becomes Chief Medical Officer at RxSightTradingView·Jul 15 at 03:33 PMRXST+0.16%
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 OutlookMarket Beat·Jul 10 at 09:01 PMRXST+0.16%ALC+0.10%
